PubMed Benign Tumors & Hyperplasia
SPDT and PDT both have shown very positive benefits to 'Benign Tumors and Hyperplasias.
Benign Prostate Hypertrophy
One of the more dramatic effects is the observed virtual elimination of symptoms of 'enlarged Prostate". This condition is virtually universal in older men with the usual symptoms of getting up at night to urinate, frequency, intermittancy, hesitancy etc. Following SPDT a near complete resolution of this condition has been noted by patients having treatment for associated problems; the elimination of the symptoms was merely a 'side' benefit. The likely outcome is this procedure may well be a replacement for the present standard treatment which is 'trans urethral resection' or TURP. Not unusual surgical complications include: impotence, incontinence, infections, pain, hematuria, huge costs etc. A painless, effective, low-cost alternative, if available, would be the overwhelming choice for most men.
The study below show the metrics of PDT's effectiveness against hypertrophic cells from a patient with 'benign prostatic hypertrophy'.
1 Mechanisms of growth inhibition of primary prostate epithelial cells following gamma irradiation or photodynamic therapy include senescence, necrosis, and autophagy, but not apoptosis
2 Benign Fibromas and NeuroFibromas
Doxycycline Potentiates Antitumor Effect of 5-aminolevulinic Acid-Mediated Photodynamic Therapy in Malignant Peripheral Nerve Sheath Tumor Cells
Neurofibromatosis type 1 (NF1) is one of the most common neurocutaneous disorders. Some NF1 patients develop benign large plexiform neurofibroma(s) at birth, which can then transform into a malignant peripheral nerve sheath tumor (MPNST). There is no curative treatment for this rapidly progressive and easily metastatic neurofibrosarcoma. Photodynamic therapy (PDT) has been developed as an anti-cancer treatment, and 5-aminolevulinic (ALA) mediated PDT (ALA-PDT) has been used to treat cutaneous skin and oral neoplasms. Doxycycline, a tetracycline derivative, can substantially reduce the tumor burden in human and animal models, in addition to its antimicrobial effects. The purpose of this study was to evaluate the effect and to investigate the mechanism of action of combined doxycycline and ALA-PDT treatment of MPNST cells.
The combined treatment inhibited tumor growth in different tumor cell lines, but not in normal human Schwann cells or fibroblasts.
Link back to Benign tumor therapy page